BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28109075)

  • 1. Knockdown of TACC3 Inhibits the Proliferation and Invasion of Human Renal Cell Carcinoma Cells.
    Guo F; Liu Y
    Oncol Res; 2018 Mar; 26(2):183-189. PubMed ID: 28109075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
    Lin H; Zeng W; Lei Y; Chen D; Nie Z
    Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TACC3 inhibits trophoblast cell migration and invasion through the PI3K/Akt signaling pathway.
    Zhu X; Cao Q; Li X; Wang Z
    Mol Med Rep; 2016 Oct; 14(4):3437-42. PubMed ID: 27572091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.
    Zhao Z; Liu H; Hou J; Li T; Du X; Zhao X; Xu W; Xu W; Chang J
    Oncol Res; 2017 May; 25(5):773-779. PubMed ID: 27983909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
    Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
    J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
    Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
    Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Serine-Arginine Protein Kinase 1 Inhibits the Growth and Migration in Renal Cell Carcinoma Cells.
    Han X; Yang J; Jia Z; Wei P; Zhang H; Lv W; Sun J; Huo Q
    Oncol Res; 2017 Mar; 25(3):389-395. PubMed ID: 27662590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
    Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
    Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
    Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
    Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family with sequence similarity 111 member B contributes to tumor growth and metastasis by mediating cell proliferation, invasion, and EMT via transforming acidic coiled-coil protein 3/PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Yang Y; Yan Z; Jiao Y; Yang W; Cui Q; Chen S
    Environ Toxicol; 2024 Jan; 39(1):409-420. PubMed ID: 37782700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways.
    Ha GH; Park JS; Breuer EK
    Cancer Lett; 2013 May; 332(1):63-73. PubMed ID: 23348690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells.
    Wu Y; Liu J; Zheng Y; You L; Kuang D; Liu T
    Tumour Biol; 2014 Dec; 35(12):11887-94. PubMed ID: 25149152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.